Another breakthrough in pursuit of battling with HIV virus has emerged which seems to be bringing very pleasant results for people suffering from AIDS. Israel has created the drug, Gammora, which has reportedly cut down about 95 percent to 97 percent of the HIV virus. Israel seems to have the ultimate cure for AIDS!
Kaplan Medical Center in Rehovot, Israel has collaborated with Zion Pharmaceuticals in conducting an experiment to create a drug that can kill a significant percentage of HIV virus to help the AIDS patients.
According to the Jewish Press, Prof. Abraham Loyter, from the Biological Chemistry Dept. of The Hebrew University of Jerusalem, made a report that they have conducted an experiment to help the AIDS patients.
The experiment was performed by injecting Gammora in test tubes containing blood samples from AIDS patients at Kaplan. Some blood is taken from the HIV carriers undergoing treatment there were also utilized in the experiment.
Prof. Loyter conducted the experiment together with Prof. Zeev Steger, head of Kaplan's Naveh or AIDS clinic. After eight days, the professors noticed an extremely favorable result from the experiment.
Prof. Loyter said, "[Gammora] is causing the death of HIV cells" as the experiment shows there was a reduction of about 95 percent to 97 percent of HIV virus in the test tubes.
This is such a phenomenal milestone in the fight to eradicate the HIV virus. The currently available drugs to help AIDS patients can only help prolong lives and enable them to live normally, however, Science has not discovered the cure to finally eliminate the virus from the patient's body.
This Israeli drug, Gammora seems to be the ultimate cure for AIDS as it can eliminate a significant amount of the killer HIV virus. Prof. Loyter explained, "In our approach, we eliminate the cells so there's no chance that the virus will return one day."
Meanwhile, the publication also inquired about the reason behind the name of the new drug, "Gammora" as it appears to be a pun linked to the "Sodom and Gomorrah" in the Bible. Ofir Levy, Kaplan Medical Center spokesperson explained that Zion Pharmaceuticals came up with a "generic choice" as a temporary name during the experiment, but the name has not been confirmed to be the final name when the drug will be launched commercially.
